Skip to content

Source filing unavailable

Q3 2018 · —
Revenue—
Net Income-$8.85Mno prior Q3 2017 on fileN/M vs Q2 2018
EPS Diluted-$0.24no prior Q3 2017 on fileno prior Q2 2018 on file

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

no prior Q3 2017 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Immunovant, Inc. · CIK 1764013 · Engraved from SEC EDGAR